Multivariate analyses for DFS and overall survival of CR patients: P values
. | All patients, n = 102 . | . | . | . | Patients from the CHEMO group, n = 86 . | . | . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | DFS . | . | Survival . | . | DFS . | . | Survival . | . | ||||||
| Age | ||||||||||||||
| Continuous variable | .009 | — | .01 | — | .02 | — | .03 | — | ||||||
| Cutpoint at 35 years | — | .002 | — | .02 | — | .003 | — | .05 | ||||||
| HR (95% CI) | — | 2.9 (1.5-5.6) | — | 2.8 (1.2-6.8) | — | 3.0 (1.5-6.2) | — | 2.5 (1.0-6.2) | ||||||
| Platelet count | ||||||||||||||
| Cutpoint at 30 g/L | — | — | .01 | .03 | — | — | .05 | .12 | ||||||
| HR (95% CI) | — | — | — | 2.3 (1.1-4.9) | — | — | — | — | ||||||
| AN status | .36 | .26 | .40 | .47 | .41 | .29 | .47 | .56 | ||||||
| Trial* | .23 | .22 | .57 | .42 | .68 | .57 | .79 | .66 | ||||||
| ALLO versus CHEMO | .53 | .62 | .71 | .62 | — | — | — | — | ||||||
| IDAC versus HDAC-2 | — | — | — | — | .31 | .36 | .54 | .46 | ||||||
. | All patients, n = 102 . | . | . | . | Patients from the CHEMO group, n = 86 . | . | . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | DFS . | . | Survival . | . | DFS . | . | Survival . | . | ||||||
| Age | ||||||||||||||
| Continuous variable | .009 | — | .01 | — | .02 | — | .03 | — | ||||||
| Cutpoint at 35 years | — | .002 | — | .02 | — | .003 | — | .05 | ||||||
| HR (95% CI) | — | 2.9 (1.5-5.6) | — | 2.8 (1.2-6.8) | — | 3.0 (1.5-6.2) | — | 2.5 (1.0-6.2) | ||||||
| Platelet count | ||||||||||||||
| Cutpoint at 30 g/L | — | — | .01 | .03 | — | — | .05 | .12 | ||||||
| HR (95% CI) | — | — | — | 2.3 (1.1-4.9) | — | — | — | — | ||||||
| AN status | .36 | .26 | .40 | .47 | .41 | .29 | .47 | .56 | ||||||
| Trial* | .23 | .22 | .57 | .42 | .68 | .57 | .79 | .66 | ||||||
| ALLO versus CHEMO | .53 | .62 | .71 | .62 | — | — | — | — | ||||||
| IDAC versus HDAC-2 | — | — | — | — | .31 | .36 | .54 | .46 | ||||||
Each column in the table represents a separate multivariate analysis.
HR indicates hazard ratio; CI, confidence interval; and —, not applicable.
LAME-91, ALFA-9000, BGMT-87, BGMT-91, GOELAM-01, or GOELAM-02.